Antihypercholesterolemic and antioxidative potential of an extract of the plant, piper betle, and its active constituent, eugenol, in triton WR-1339-Induced hypercholesterolemia in experimental rats

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Venkadeswaran, Karuppasamy ^a   Muralidharan, Arumugam Ramachandran ^a   Annadurai, Thangaraj ^a   Ruban, Vasanthakumar Vasantha ^a   Sundararajan, Mahalingam ^a   Anandhi, Ramalingam ^a   Thomas, Philip A ^b   Geraldine, Pitchairaj ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b JOSEPH EYE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BETEL EXTRACT; EUGENOL; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MEVINOLIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; LIVER; NONHUMAN; PIPER BETLE; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84893182728     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/478973     Document Type: Article

References (63)

1. Morsy M. A., Fouad A. A., Mechanisms of gastroprotective effect of eugenol in indomethacin-induced ulcer in rats. Phytotherapy Research 2008 22 10 1361 1366 2-s2.0-55449117707 10.1002/ptr.2502
2. Freedman J. E., High-fat diets and cardiovascular disease: are nutritional supplements useful? Journal of the American College of Cardiology 2003 41 10 1750 1752 2-s2.0-0038239549 10.1016/S0735-1097(03)00303-6 (Pubitemid 36584247)
3. Jain K. S., Kulkarni R. R., Jain D. P., Current drug targets for antihyperlipidemic therapy. Mini Reviews in Medicinal Chemistry 2010 10 3 232 262 2-s2.0-77954743805
4. Amundsen Å. L., Ose L., Nenseter M. S., Ntanios F. Y., Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. American Journal of Clinical Nutrition 2002 76 2 338 344 2-s2.0-0036078545 (Pubitemid 34804054)
5. Ichihashi T., Izawa M., Miyata K., Mizui T., Hirano K., Takagishi Y., Mechanism of hypocholesterolemic action of S-8921 in rats: S-8921 inhibits ileal bile acid absorption. Journal of Pharmacology and Experimental Therapeutics 1998 284 1 43 50 2-s2.0-0031887502 (Pubitemid 28109527)
6. Shi W., Haberland M. E., Jien M.-L., Shih D. M., Lusis A. J., Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 2000 102 1 75 81 2-s2.0-0034604223 (Pubitemid 30430556)
7. Tribble D. L., Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and β -carotene: a statement for healthcare professionals from the American Heart Association. Circulation 1999 99 4 591 595 2-s2.0-0033514107 (Pubitemid 29061878)
8. Hopps E., Noto D., Caimi G., Averna M. R., A novel component of the metabolic syndrome: the oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases 2010 20 1 72 77 2-s2.0-72649106550 10.1016/j.numecd. 2009.06.002
9. Duarte M. M. M. F., Rocha J. B. T., Moresco R. N., Duarte T., Da Cruz I. B. M., Loro V. L., Schetinger M. R. C., Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clinical Biochemistry 2009 42 7-8 666 671 2-s2.0-63649104698 10.1016/j.clinbiochem.2009.01.010
10. Ahmad I., Mehmood Z., Mohammad F., Screening of some Indian medicinal plants for their antimicrobial properties. Journal of Ethnopharmacology 1998 62 2 183 193 2-s2.0-0031716747 10.1016/S0378-8741(98)00055-5 (Pubitemid 28400990)
11. Koff R. S., Gordan G., Sabesin S. M., D-Galactosamine hepatitis hepatocellular injury and fatty liver following a single dose. Proceedings of the Society for Experimental Biology and Medicine 1971 137 696 701
12. Chakraborty D., Shah B., Antimicrobial, anti-oxidative and anti-hemolytic activity of Piper betel leaf extracts. International Journal of Pharmacy and Pharmaceutical Sciences 2011 3 3 192 199 2-s2.0-79957797369
13. Nagababu E., Lakshmaiah N., Inhibitory effect of eugenol on non-enzymatic lipid peroxidation in rat liver mitochondria. Biochemical Pharmacology 1992 43 11 2393 2400 10.1016/0006-2952(92)90318-D
14. Kabuto H., Tada M., Kohno M., Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biological and Pharmaceutical Bulletin 2007 30 3 423 427 2-s2.0-33847644599 10.1248/bpb.30.423 (Pubitemid 46355914)
15. World Health Organization, FAO/WHO expert committee on food additives evaluation of certain food additives and contaminants. 1982 683 Geneva, Switzerland WHO
16. Rimando A. M., Han B. H., Park J. H., Cantoria M. C., Studies on the constituents of Philippine Piper betle leaves. Archives of Pharmacal Research 1986 9 2 93 97 2-s2.0-0343141706 10.1007/BF02857217
17. Manigauha A., Patel S., Ali H., Chandy A., Uma Maheshwari M., Study the effect of phytochemical constituents of Piper betle leaves extracts on liver disorders by in vivo model. Journal of Pharmacy Research 2009 2 353 356
18. Schurr P. E., Schultz J. R., Parkinson T. M., Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids 1972 7 1 68 74 2-s2.0-0015254532 10.1007/BF02531272
19. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry 1976 72 1-2 248 254 2-s2.0-0017184389
20. Sasaki T., Matzy S., Sonal A., Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku 1972 1 346 353
21. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
22. King J., Van D., The transferases-alanine and aspartate transaminases. Practical Clinical Enzymology 1965 London, UK D. Van Nostrand 121 138
23. King J., Van D., The hydrolases-acid and alkaline phosphatases. Practical Clinical Enzymology 1965 London, UK D. Van Nostrand 191 208
24. King J., Van D., The dehydrogenases or oxidoreductases lactate dehydrogenase. Practical Clinical Enzymology 1965 London, UK D. Van Nostrand
25. Sinha A. K., Colorimetric assay of catalase. Analytical Biochemistry 1972 47 2 389 394 2-s2.0-0015353270
26. Marklund S., Marklund G., Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European Journal of Biochemistry 1974 47 3 469 474 2-s2.0-0016272750
27. Rotruck J. T., Pope A. L., Ganther H. E., Swanson A. B., Hafeman D. G., Hoekstra W. G., Selenium: biochemical role as a component of glatathione peroxidase. Science 1973 179 4073 588 590 2-s2.0-0015918166
28. Habig W. H., Jakoby W. B., [51] Assays for differentiation of glutathione S-Transferases. Methods in Enzymology 1981 77 398 405 2-s2.0-0019741605 10.1016/S0076-6879(81)77053-8
29. Moron M. S., Depierre J. W., Mannervik B., Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 1979 582 1 67 78 2-s2.0-0018327389 (Pubitemid 9065588)
30. Omaye S. T., David Turnbull J., Sauberlich H. E., [1] Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods in Enzymology 1979 62 3 11 2-s2.0-0018369625 10.1016/0076-6879(79)62181- X
31. Desai I. D., Vitamin E analysis methods for animal tissues. Methods in Enzymology 1984 105 138 147 2-s2.0-0021288822 (Pubitemid 14165381)
32. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
33. Drury R. A. B., Wallington E. A., Wallington, Carleton's Histological Technique 1980 New York, NY, USA Oxford University Press
34. Byers S. O., Fiedman M., Sugiyama T., Triton hypercholesteremia: cause or consequence of augmented cholesterol synthesis. The American Journal of Physiology 1963 204 1100 1102 2-s2.0-75449136106
35. Harnafi H., Serghini Caid H., el Houda Bouanani N., Aziz M., Amrani S., Hypolipemic activity of polyphenol-rich extracts from Ocimum basilicum in Triton WR-1339-induced hyperlipidemic mice. Food Chemistry 2008 108 1 205 212 2-s2.0-37549018947 10.1016/j.foodchem.2007.10.062
36. Ansarullah A., Jadeja R., Thounaojam M., Patel V., Devkar R., Ramachandran A., Antihyperlipidemic potential of a polyherbal preparation on Triton WR 1339 (Tyloxapol) induced hyperlipidemia: a comparison with lovastatin. International Journal of Green Pharmacy 2009 3 2 119 124 2-s2.0-77649186018 10.4103/0973-8258.54900
37. Vijayaraj P., Muthukumar K., Sabarirajan J., Nachiappan V., Antihyperlipidemic activity of Cassia auriculata flowers in triton WR 1339 induced hyperlipidemic rats. Experimental and Toxicologic Pathology 2013 1-2 135 141 2-s2.0-80051589820 10.1016/j.etp.2011.07.001
38. Lee S.-J., Ko J.-H., Lim K., Lim K.-T., 150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse. Pharmacological Research 2005 51 5 399 408 2-s2.0-14644399259 10.1016/j.phrs.2004.11.004 (Pubitemid 40321009)
39. Shattat G., Al-Qirim R., Al-Hiari Y., Sheikha G. A., Al-Qirim T., El-Huneidi W., Shahwan M., Synthesis and anti-hyperlipidemic evaluation of N-(benzoylphenyl)-5-fluoro- 1H-indole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats. Molecules 2010 15 9 5840 5849 2-s2.0-77957297949 10.3390/molecules15095840
40. Shattat G., Al-Qirim T., Sweidan K., Shahwan M., El-Huneidi W., Al-Hiari Y., The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate. Journal of Enzyme Inhibition and Medicinal Chemistry 2010 25 6 751 755 2-s2.0-78149451332 10.3109/14756360903389880
41. Ågren J. J., Kurvinen J.-P., Kuksis A., Isolation of very low density lipoprotein phospholipids enriched in ethanolamine phospholipids from rats injected with Triton WR 1339. Biochimica et Biophysica Acta 2005 1734 1 34 43 2-s2.0-18144387240 10.1016/j.bbalip.2005.02.001 (Pubitemid 40615218)
42. Holt P. R., Dominguez A. A., Triton-induced hyperlipidemia: a model for studies of intestinal lipoprotein production. The American Journal of Physiology 1980 238 5 G453 G457 2-s2.0-0019013371 (Pubitemid 10114041)
43. Khanna A. K., Rizvi F., Chander R., Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. Journal of Ethnopharmacology 2002 82 1 19 22 2-s2.0-0036708094 10.1016/S0378-8741(02)00136-8
44. Davey Smith G., Pekkanen J., Should there be a moratorium on the use of cholesterol lowering drugs? British Medical Journal 1992 304 6824 431 434 2-s2.0-0026527178
45. Malloy M. J., Kane J. P., Medical management of hyperlipidemic states. Advances in Internal Medicine 1994 39 603 631 2-s2.0-0028188438
46. Hokanson J. E., Austin M. A., Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 1996 3 2 213 219 2-s2.0-0029838433 (Pubitemid 26266496)
47. Austin M. A., Hokanson J. E., Brunzell J. D., Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Current Opinion in Lipidology 1994 5 6 395 403 2-s2.0-0028580414
48. Murakami T., Michelagnoli S., Longhi R., Gianfranceschi G., Pazzucconi F., Calabresi L., Sirtori C. R., Franceschini G., Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 11 1819 1828 2-s2.0-0028883659
49. Thomas M. J., Physiological aspects of low density lipoprotein oxidation. Current Opinion in Lipidology 2000 11 297 301 (Pubitemid 30336028)
50. Vallianou I., Peroulis N., Pantazis P., Hadzopoulou-Cladaras M., Camphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-CoA reductase activity. PLoS ONE 2011 6 11 2-s2.0-80455125864 10.1371/journal.pone.0020516 e20516
51. Küçükgergin C., AydIn A. F., Özdemirler-Erata G., Mehmetçik G., Koçak-Toker N., Uysal M., Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet. Biological Trace Element Research 2010 135 1-3 264 274 2-s2.0-77951938743 10.1007/s12011-009-8484-9
52. Molander D. W., Wroblewski F., ladue J. S., Serum glutamic oxalacetic transaminase as an index of hepatocellular integrity. Journal of Laboratory and Clinical Medicine 1955 6 831 839
53. Anandhi R., Annadurai T., Anitha T. S., Muralidharan A. R., Najmunnisha K., Nachiappan V., Thomas P. A., Geraldine P., Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats. Journal of Physiology and Biochemistry 2013 69 2 313 323 10.1007/s13105-012-0215-6
54. Prasad K., Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999 99 10 1355 1362 2-s2.0-0033574164 (Pubitemid 29129922)
55. Halliwell B., Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovascular Research 2000 47 3 410 418 2-s2.0-0034682916 10.1016/S0008-6363(00)00097-3 (Pubitemid 30646063)
56. Sheela C. G., Augusti K. T., Antiperoxide effects of S-allyl cysteine sulphoxide isolated from Allium sativum Linn and gugulipid in cholesterol diet fed rats. Indian Journal of Experimental Biology 1995 33 5 337 341 2-s2.0-0028947141
57. Klaassen C. D., Bracken W. M., Dudley R. E., Goering P. L., Hazelton G. A., Hjelle J. J., Role of sulfhydryls in the hepatotoxicity of organic and metallic compounds. Toxicological Sciences 1985 5 5 806 815 2-s2.0-77957186385 10.1093/toxsci/5.5.806 (Pubitemid 16169613)
58. Traber M. G., Sies H., Vitamin E in humans: demand and delivery. Annual Review of Nutrition 1996 16 321 347 2-s2.0-0029798873 (Pubitemid 26286857)
59. Freeman B. A., Crapo J. D., Biology of disease. Free radicals and tissue injury. Laboratory Investigation 1982 47 5 412 426 2-s2.0-0020427486 (Pubitemid 13229679)
60. Prasad K., Kalra J., Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. American Heart Journal 1993 125 4 958 973 2-s2.0-0027474868 10.1016/0002-8703(93)90102-F (Pubitemid 23117326)
61. Niki E., Shimasaki H., Mino M., Antioxidant-Free Radical and Biological Defence 1994 Tokyo, Japan Gakkai-Shuppan Center
62. Deepa P. R., Varalakshmi P., Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clinica Chimica Acta 2004 339 1-2 105 115 2-s2.0-0346366548 10.1016/j.cccn.2003. 09.021 (Pubitemid 37542464)
63. Sudhahar V., Kumar S. A., Varalakshmi P., Role of lupeol and lupeol linoleate on lipemic-oxidative stress in experimental hypercholesterolemia. Life Sciences 2006 78 12 1329 1335 2-s2.0-32044454032 10.1016/j.lfs.2005.07.011 (Pubitemid 43199954)